Christophe OD - Search Results

1

Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B platelets.

Casari C, Paul DS, Susen S, Lavenu-Bombled C, Harroche A, Piatt R, Poe KO, Lee RH, Bryckaert M, Christophe OD, Lenting PJ, Denis CV, Bergmeier W. Casari C, et al. Among authors: christophe od. Blood Adv. 2018 Jun 26;2(12):1417-1428. doi: 10.1182/bloodadvances.2017014290. Blood Adv. 2018. PMID: 29925524 Free PMC article.

2

The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.

Christophe O, Obert B, Meyer D, Girma JP. Christophe O, et al. Blood. 1991 Nov 1;78(9):2310-7. Blood. 1991. PMID: 1834252 Free article.

3

A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease.

Christophe O, Rouault C, Obert B, Piétu G, Meyer D, Girma JP. Christophe O, et al. Br J Haematol. 1995 May;90(1):195-203. doi: 10.1111/j.1365-2141.1995.tb03400.x. Br J Haematol. 1995. PMID: 7540413 Clinical Trial.

4

Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand factor.

Christophe O, Ribba AS, Baruch D, Obert B, Rouault C, Niinomi K, Piétu G, Meyer D, Girma JP. Christophe O, et al. Blood. 1994 Jun 15;83(12):3553-61. Blood. 1994. PMID: 8204881 Free article.

5

Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease.

Ribba AS, Christophe O, Derlon A, Cherel G, Siguret V, Lavergne JM, Girma JP, Meyer D, Pietu G. Ribba AS, et al. Blood. 1994 Feb 1;83(3):833-41. Blood. 1994. PMID: 8298143 Free article.

6

Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen.

Denis C, Baruch D, Kielty CM, Ajzenberg N, Christophe O, Meyer D. Denis C, et al. Arterioscler Thromb. 1993 Mar;13(3):398-406. doi: 10.1161/01.atv.13.3.398. Arterioscler Thromb. 1993. PMID: 8443144

7

Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.

Lenting PJ, Christophe OD, Maat H, Rees DJ, Mertens K. Lenting PJ, et al. Among authors: christophe od. J Biol Chem. 1996 Oct 11;271(41):25332-7. doi: 10.1074/jbc.271.41.25332. J Biol Chem. 1996. PMID: 8810297 Free article.

8

Characterization of recombinant von Willebrand factors mutated on cysteine 509 or 695.

Siguret V, Ribba AS, Christophe O, Chérel G, Obert B, Rouault C, Nishikubo T, Meyer D, Girma JP, Piétu G. Siguret V, et al. Thromb Haemost. 1996 Sep;76(3):453-9. Thromb Haemost. 1996. PMID: 8883286

9

Abnormal proteolytic processing of von Willebrand factor Arg611 Cys and Arg611His.

Nishikubo T, Christophe O, Lavergne JM, Obert B, Nonami K, Takahashi Y, Yoshioka A, Meyer D, Girma JP. Nishikubo T, et al. Thromb Haemost. 1997 Jan;77(1):174-82. Thromb Haemost. 1997. PMID: 9031470

10

Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain.

Christophe OD, Lenting PJ, Kolkman JA, Brownlee GG, Mertens K. Christophe OD, et al. J Biol Chem. 1998 Jan 2;273(1):222-7. doi: 10.1074/jbc.273.1.222. J Biol Chem. 1998. PMID: 9417068 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters